In today’s briefing:
- Balaji Speciality Chemicals Pre-IPO – Stupendous Growth but Likely to Normalize
Balaji Speciality Chemicals Pre-IPO – Stupendous Growth but Likely to Normalize
- Balaji Speciality Chemicals (1742663D IN) is looking to raise about US$126m in its upcoming India IPO.
- Balaji Speciality Chemicals (BSC) is the sole manufacturer in India of niche chemicals such as Ethylenediamine, Piperazine (Anhydrous), Diethylenetriamine, Amino Ethyl Ethanol Amines and Amino Ethyl Piperazine, according to CRISIL.
- BSC’s profitability growth has been stupendous, given its quick production ramp up. However, its growth is very likely to normalize.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
